SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Tiegs G, Hentschel J, Wendel A. A T cell-dependent experimental liver injury in mice inducible by concanavalin A. J Clin Invest 1992; 90:196203.MEDLINE
  • 2
    Mizuhara H, O'Neil E, Seki N, Ogawa T, Kusunoki C, Otsuka K, Satoh S, et al. T cell activation-associated hepatic injury: mediation by tumor necrosis factors and protection by interleukin 6. J Exp Med 1994; 179:15291537.MEDLINE
  • 3
    Fujikura S, Mizuhara H, Miyazawa Y, Fujiwara H, Kaneda K. Kinetics and localization of lymphoblasts that proliferate in the murine liver after concanavalin A-administration. Biomed Res 1996; 17:129139.
  • 4
    Watanabe Y, Morita M, Akaike T. Concanavalin A induces perforin-mediated but not Fas-mediated hepatic injury. Hepatology 1996; 24:702710.MEDLINE
  • 5
    Gantner F, Leist M, Lohse AW, Germann PG, Tiegs G. Concanavalin A-induced T-cell-mediated hepatic injury in mice: the role of tumor necrosis factor. Hepatology 1995; 21:190198.MEDLINE
  • 6
    Mizuhara H, Uno M, Seki N, Yamashita M, Yamaoka M, Ogawa T, Kaneda K, et al. Critical involvement of interferon-γ in the pathogenesis of T cell activation-associated hepatitis and regulatory mechanism of interleukin-6 for the manifestations of hepatitis. Hepatology 1996; 23:16081615.MEDLINE
  • 7
    Kusters S, Gantner F, Kunstle G, Tiegs G. Interferon gamma plays a critical role in T cell-dependent liver injury in mice initiated by concanavalin A. Gastroenterology 1996; 111:462471.MEDLINE
  • 8
    Endo Y. A lipopolysaccharide and concanavalin A induce variations of serotonin levels in mouse tissues. Eur J Pharmac 1983; 91:493499.
  • 9
    Ferran C, Sheehan K, Cy M, Schreiber R, Merite S, Landais P, Noel L-H, et al. Cytokine-related syndrome following injection of anti-CD3 monoclonal antibody: further evidence for transient in vivo T cell activation. Eur J Immunol 1990; 20:509515.MEDLINE
  • 10
    Arvidsson D, Svensson H, Haglund U. Laser-Doppler flowmetry for estimating liver blood flow. Am J Physiol 1988; 254:G471476.MEDLINE
  • 11
    Leist M, Gantner F, Bohlinger I, Tiegs G, Germann PG, Wendel A. Tumor necrosis factor-induced hepatocyte apoptosis precedes liver failure in experimental murine shock models. Am J Pathol 1995; 146:12201234.MEDLINE
  • 12
    Ikeda K, Kubo S, Hirohashi K, Kinoshita H, Kaneda K. The ultrastructure, kinetics and intralobular distribution of apoptotic hepatocytes after portal branch ligation with special reference to their relationship to necrotic hepatocytes. Arch Histol Cytol 1995; 58:171184.MEDLINE
  • 13
    Russo PA, Yunis EJ. Subcapsular hepatic necrosis in orthotopic liver grafts. Hepatology 1986; 6:708713.MEDLINE
  • 14
    Cheville NF. Ultrastructural Pathology. Ames; Iowa State University Press, 1994:411413.
  • 15
    Conway JG, Popp JA, Thurman RG. Microcirculation in periportal and pericentral regions of lobule in perfused rat liver. Am J Physiol 1985; 249:G449G456.MEDLINE
  • 16
    McCuskey RS, Urbaschek R, McCuskey PA, Urbaschek B. Hepatic microvascular responses to tumor necrosis factor. In: WisseE, KnookDL, DeckerK, eds. Cells of the Hepatic Sinusoid. Vol 2. Rijiswijk: The Kupffer Cell Foundation, 1989;272276.
  • 17
    Schlayer HJ, Laaf H, Peter T, Woort-Menker M, Estler C, Karck U, Schaefer HE, et al. Involvement of tumor necrosis factor in endotoxin-triggered neutrophil adherance to sinusoidal endothelial cells of mouse liver and its modulation in acute phase. J Hepatol 1988; 7:239249.MEDLINE
  • 18
    Endo Y, Nakamura M. The effect of lipopolysaccharide, interleukin-1 and tumor necrosis factor on the hepatic accumulation of 5-hydroxytryptamine and platelets in the mouse. Br J Pharmac 1992; 105:613619.
  • 19
    Endo Y, Nakamura M. Active translocation of platelets into sinusoidal and Disse spaces in the liver in response to lipopolysaccharides, interleukin-1 and tumor necrosis factor. Gen Pharmac 1993; 24:10391053.
  • 20
    Todoroki N, Watanabe Y, Akaike T, Katagiri Y, Tanoui K, Yamazaki H, Tsuji T, et al. Enhancement by IL-1β and IFN-γ of platelet activation. Adhesion to leukocytes via GMP-140/PADGEM protein (CD62). Biochem Biophys Res Commun 1991; 179:756761.MEDLINE
  • 21
    Tijburg PNM, Ryan J, Stern DM, Wollitzky B, Rimon S, Rimon A, Handley D, et al. Activation of the coagulation mechanism on tumor necrosis factor-stimulated cultured endothelial cells and their extracellular matrix. J. Biol Chem 1991; 266:1206712074.
  • 22
    Stern D, Bank I, Nawroth P, Cassimeris J, Kisiel W, Fenton JW, Dinarello C, et al. Self-regulation of procoagulant events on the endothelial cell surface. J Exp Med 1985; 162:12231228.MEDLINE
  • 23
    Nawroth P, Stern D. Modulation of endothelial cell hemostatic properties by tumor necrosis factor. J Exp Med 1986; 164:740749.
  • 24
    Yamada S, Ogata I, Hirata K, Mochida S, Tomiya T, Fujiwara K. Intravascular coagulation in the development of massive hepatic necrosis induced by Corynebacterium parvum and endotoxin in rats. Scand J Gastroenterol 1989; 24:293298.MEDLINE
  • 25
    Arai M, Mochida S, Ohno A, Ogata I, Fujiwara K. Sinusoidal endothelial cell damage by activated macrophages in rat liver necrosis. Gastroenterology 1993; 104:14661471.MEDLINE
  • 26
    Gantner F, Leist M, Jilg S, Germann PG, Freudenberg MA, Tiegs G. Tumor necrosis factor-induced hepatic DNA fragmentation as an early marker of T cell-dependent liver injury in mice. Gastroenterology 1995; 109:166176.MEDLINE
  • 27
    Talmadge JE, Bowersox O, Tribble H, Lee SH, Shepard HM, Liggitt D. Toxicity of tumor necrosis factor is synergistic with γ-interferon and can be reduced with cyclooxygenase inhibitors. Am J Pathol 1987; 128:410425.MEDLINE
  • 28
    Smith SR, Terminelli C, Kenworthy-Bott L, Calzetta A, Donkin J. The cooperative effects of TNF-α and IFN-γ are determining factors in the ability of IL-10 to protect mice from lethal endotoxemia. J Leukoc Biol 1994; 55:711718.MEDLINE
  • 29
    Blankenship Jr LL, Cilento EV, Reilly RD. Hepatic microvascular regulatory mechanisms. XI. Effects of serotonin on intralobular perfusion and volumetric flow rates at the inlet of periportal and outlet of centrilobular sinusoids. Microcirc Endothelium Lymphatics 1991; 7:5775.MEDLINE
  • 30
    Wanless IR. Vascular disorders. In: MacSweenRNM, AnthonyPP, ScheuerPJ, BurtAD, PortmannBC, eds. Pathology of the Liver. 3rd Ed. Edinburgh: Churchill Livingstone, 1994;535562.
  • 31
    Kanel GC, Ucci AA, Kaplan MM, Wolfe HJ. A distinctive perivenular hepatic lesion associated with heart failure. Am J Clin Pathol 1980; 73:235239.MEDLINE
  • 32
    Wisse E, De Zanger RB, Charels K, Van der Smissen P, McCuskey RS. The liver sieve: considerations concerning the structure and function of endothelial fenestrae, the sinusoidal wall and the space of Disse. Hepatology 1985; 5:683692.MEDLINE
  • 33
    McCuskey RS. The hepatic microvascular system. In: AriasIM, BoyerJL, FaustoN, JakobyWB, SchachterDA, ShafritzDA, eds. The Liver: Biology and Pathobiology. 3rd Ed. New York: Raven Press, 1994;10891106.
  • 34
    Wake K, Motomatsu K, Dan C, Kaneda K. Three-dimensional structure of endothelial cells in hepatic sinusoids of the rat as revealed by the Golgi method. Cell Tiss Res 1988; 253:563571.